Company intelligence / Profile preview

Real Imaging

Ownership: Private
Development stage: Commercial

Overview

Real Imaging develops advanced, patient-friendly diagnostic imaging solutions for breast cancer. Its proprietary technology aims to increase correct detection rates and reduce false diagnoses. The company’s MIRA solution utilizes dual-head structured-light technology. RealView Imaging, a related entity in the same sector from Israel, has completed the world’s first in-human clinical trials evaluating live 3D holographic imaging in interventional cardiology and received FDA clearance for its HOLOSCOPE™-i system. However, "Real Imaging" as described here is focused on breast cancer diagnostics rather than holography.

Therapeutic areas: Oncology
Modalities: DeviceNon-pharmacological therapy (diagnostic imaging)
Industry: Medical Imaging

Beyond the preview

Go deeper on Real Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Real Imaging.

Explore the full profile